Dear Colleagues:
On behalf of the University of Cincinnati and Current Psychiatry, it is my pleasure to invite you to attend our 21st Annual Psychopharmacology Update on Saturday October 29, 2022. This year the conference will be a hybrid event, giving those unable to be in Cincinnati an opportunity to take advantage of the same valuable educational information as those attending in person.
At this full-day course, nationally renowned faculty will be a teaching a Masterclass focusing on treatment-resistance in multiple psychiatric syndromes.
Part 1 will focus on Schizophrenia, Delusional and Schizo-affective Disorders, Part 2 will cover Anxiety Disorders, and Part 3 will close the day looking at Mood Disorders.
We have updated our PRECONFERENCE WORKSHOPS with the latest advances in Addiction, Medical Cannabis and Telepsychiatry. These will take place the day before on Friday, October 28th, 2022. Also on Friday, we are excited to announce a KEYNOTE PRESENTATION on Management of Treatment Resistant Depression by Charles B. Nemeroff, MD, PhD.
This popular CME_CE symposium, now in its 21st year, offers an outstanding opportunity for education with minimal disruption to your busy schedule. In addition to the workshops and educational sessions, you will have the opportunity to network with colleagues and explore the exhibit hall. Attendees joining remotely can interact in the virtual lounge and participate in the Q&A sessions via the chat feature on our virtual platform.
I look forward to once again hosting this exciting and important conference, and to seeing our past participants, along with many new faces as well!
Cordially,
Henry A. Nasrallah, MD
Symposium Director
CONFERENCE CHAIR
KEYNOTE SPEAKER
Current and Future Treatment of Depression: Glass Half Full or Half Empty
October 28, 2022
4:30 PM ET
Moderated by Henry Nasrallah, MD
Join Dr. Nasrallah and Dr. Nemeroff for a cutting-edge presentation on managing treatment-resistant depression, exploring new and emerging treatments.
Charles B. Nemeroff, MD, PhD
Professor & Chair, Department of Psychiatry & Behavioral Sciences, University of Texas at Austin Dell Medical School
Charles B. Nemeroff, MD, PhD is Professor and Chair of the Department of Psychiatry and Behavioral Sciences at the Dell Medical School, University of Texas at Austin. He also directs the Institute for Early Life Adversity Research within the department as part of the Mulva Clinic for the Neurosciences, and co-directs the Center for Psychedelic Research and Therapy. Prior to joining Dell Med, Dr. Nemeroff was chair of the Department of Psychiatry and Behavioral Sciences and clinical director of the Center on Aging at the University of Miami Miller School of Medicine in Miami, Florida. He received his medical degree and doctorate degrees in neurology from the University of North Carolina (UNC) School of Medicine.
AGENDA
Select a session below to view more details.
